JP2005341964A - 鹿角霊芝を含有した健康食品及びその製造方法 - Google Patents
鹿角霊芝を含有した健康食品及びその製造方法 Download PDFInfo
- Publication number
- JP2005341964A JP2005341964A JP2005128014A JP2005128014A JP2005341964A JP 2005341964 A JP2005341964 A JP 2005341964A JP 2005128014 A JP2005128014 A JP 2005128014A JP 2005128014 A JP2005128014 A JP 2005128014A JP 2005341964 A JP2005341964 A JP 2005341964A
- Authority
- JP
- Japan
- Prior art keywords
- health food
- reishi
- yeast
- lactic acid
- food containing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000013402 health food Nutrition 0.000 title claims abstract description 50
- 240000008397 Ganoderma lucidum Species 0.000 title claims abstract description 48
- 235000001637 Ganoderma lucidum Nutrition 0.000 title claims abstract description 48
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 24
- 241000282994 Cervidae Species 0.000 title claims abstract description 18
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims abstract description 76
- 241000894006 Bacteria Species 0.000 claims abstract description 45
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 44
- 235000014655 lactic acid Nutrition 0.000 claims abstract description 38
- 239000004310 lactic acid Substances 0.000 claims abstract description 38
- 239000000463 material Substances 0.000 claims abstract description 7
- 235000009467 Carica papaya Nutrition 0.000 claims description 35
- 241000219173 Carica Species 0.000 claims description 34
- 239000007788 liquid Substances 0.000 claims description 22
- 241000233866 Fungi Species 0.000 claims description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- OOYGSFOGFJDDHP-KMCOLRRFSA-N kanamycin A sulfate Chemical group OS(O)(=O)=O.O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N OOYGSFOGFJDDHP-KMCOLRRFSA-N 0.000 claims description 5
- 210000003056 antler Anatomy 0.000 claims description 4
- 235000014676 Phragmites communis Nutrition 0.000 claims description 3
- 241000289692 Myrmecophagidae Species 0.000 claims description 2
- 235000001497 healthy food Nutrition 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 abstract description 31
- 230000000694 effects Effects 0.000 abstract description 29
- 201000010099 disease Diseases 0.000 abstract description 19
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 19
- 206010020772 Hypertension Diseases 0.000 abstract description 8
- 206010028980 Neoplasm Diseases 0.000 abstract description 8
- 201000011510 cancer Diseases 0.000 abstract description 8
- 206010020751 Hypersensitivity Diseases 0.000 abstract description 7
- 230000007815 allergy Effects 0.000 abstract description 7
- 206010012601 diabetes mellitus Diseases 0.000 abstract description 7
- 230000001747 exhibiting effect Effects 0.000 abstract description 3
- 208000026935 allergic disease Diseases 0.000 abstract description 2
- 244000005700 microbiome Species 0.000 abstract 3
- 206010020880 Hypertrophy Diseases 0.000 abstract 1
- 230000002440 hepatic effect Effects 0.000 abstract 1
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 37
- 241000222336 Ganoderma Species 0.000 description 28
- 238000000855 fermentation Methods 0.000 description 17
- 230000004151 fermentation Effects 0.000 description 17
- 230000009471 action Effects 0.000 description 16
- 210000004027 cell Anatomy 0.000 description 11
- 210000000170 cell membrane Anatomy 0.000 description 11
- 210000000936 intestine Anatomy 0.000 description 10
- 230000006872 improvement Effects 0.000 description 9
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 8
- 239000008280 blood Substances 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 8
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 7
- 238000001035 drying Methods 0.000 description 7
- 239000008103 glucose Substances 0.000 description 7
- 210000004185 liver Anatomy 0.000 description 7
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 229920002498 Beta-glucan Polymers 0.000 description 6
- 235000000346 sugar Nutrition 0.000 description 6
- 238000010521 absorption reaction Methods 0.000 description 5
- 230000000968 intestinal effect Effects 0.000 description 5
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 4
- 229960005305 adenosine Drugs 0.000 description 4
- 230000001093 anti-cancer Effects 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 208000026106 cerebrovascular disease Diseases 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 210000001035 gastrointestinal tract Anatomy 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 150000008163 sugars Chemical class 0.000 description 4
- 206010039897 Sedation Diseases 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000004913 activation Effects 0.000 description 3
- 238000007605 air drying Methods 0.000 description 3
- 230000036592 analgesia Effects 0.000 description 3
- 230000003266 anti-allergic effect Effects 0.000 description 3
- -1 chitin and β-glucan Chemical class 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 229910052732 germanium Inorganic materials 0.000 description 3
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 3
- 230000003204 osmotic effect Effects 0.000 description 3
- 230000002572 peristaltic effect Effects 0.000 description 3
- 230000036280 sedation Effects 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000186000 Bifidobacterium Species 0.000 description 2
- 229920002101 Chitin Polymers 0.000 description 2
- 241000193468 Clostridium perfringens Species 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 206010008118 cerebral infarction Diseases 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 238000007791 dehumidification Methods 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 210000004211 gastric acid Anatomy 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 239000002917 insecticide Substances 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 238000003825 pressing Methods 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000000644 propagated effect Effects 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 241000222518 Agaricus Species 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 241000219172 Caricaceae Species 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241000255925 Diptera Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 206010061459 Gastrointestinal ulcer Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 108090000526 Papain Proteins 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 102100029677 Trehalase Human genes 0.000 description 1
- 108010087472 Trehalase Proteins 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 239000003613 bile acid Substances 0.000 description 1
- 102000023732 binding proteins Human genes 0.000 description 1
- 108091008324 binding proteins Proteins 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 150000001765 catechin Chemical class 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 230000020411 cell activation Effects 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 235000019621 digestibility Nutrition 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 125000000082 organogermanium group Chemical group 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 235000019419 proteases Nutrition 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000005070 ripening Effects 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000021092 sugar substitutes Nutrition 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
【解決手段】 鹿角霊芝と、少なくとも酵母菌及び乳酸菌を含む菌類とから成る鹿角霊芝を含有した健康食品。
【選択図】 なし
Description
Claims (9)
- 鹿角霊芝と、該鹿角霊芝を発酵させる菌類とから成ることを特徴とする鹿角霊芝を含有した健康食品。
- 請求項1記載の鹿角霊芝を含有した健康食品において、菌類として、少なくとも酵母菌及び乳酸菌を含む菌類含有物を採用したこと特徴とする鹿角霊芝を含有した健康食品。
- 請求項2記載の鹿角霊芝を含有した健康食品において、少なくとも酵母菌及び乳酸菌を含む菌類含有物として、パパイヤを酵母菌及び乳酸菌により発酵して形成した発酵パパイヤ液を採用したことを特徴とする鹿角霊芝を含有した健康食品。
- 請求項1〜3いずれか1項に記載の鹿角霊芝を含有した健康食品において、鹿角霊芝として、鹿角霊芝から抽出した鹿角霊芝エキスを採用したことを特徴とする鹿角霊芝を含有した健康食品。
- 鹿角霊芝に、少なくとも酵母菌及び乳酸菌を含む菌類を加えて該鹿角霊芝を発酵させ、これにより得た発酵液を健康食品とすることを特徴とする鹿角霊芝を含有した健康食品の製造方法。
- 請求項5記載の鹿角霊芝を含有した健康食品の製造方法において、菌類として、少なくとも酵母菌及び乳酸菌を含む菌類含有物を採用したことを特徴とする鹿角霊芝を含有した健康食品の製造方法。
- 請求項6記載の鹿角霊芝を含有した健康食品の製造方法において、パパイヤを酵母菌及び乳酸菌により発酵して形成した発酵パパイヤ液を採用したことを特徴とする鹿角霊芝を含有した健康食品の製造方法。
- 請求項5〜7いずれか1項に記載の鹿角霊芝を含有した健康食品の製造方法において、鹿角霊芝として、鹿角霊芝から抽出した鹿角霊芝エキスを採用したことを特徴とする鹿角霊芝を含有した健康食品の製造方法。
- 請求項5〜8いずれか1項に記載の鹿角霊芝を含有した健康食品の製造方法において、発酵液を乾燥させて水分量を所定の量まで減少させることを特徴とする鹿角霊芝を含有した健康食品の製造方法。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005128014A JP4126053B2 (ja) | 2004-05-06 | 2005-04-26 | 鹿角霊芝を含有した健康食品の製造方法 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004137520 | 2004-05-06 | ||
JP2005128014A JP4126053B2 (ja) | 2004-05-06 | 2005-04-26 | 鹿角霊芝を含有した健康食品の製造方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2005341964A true JP2005341964A (ja) | 2005-12-15 |
JP4126053B2 JP4126053B2 (ja) | 2008-07-30 |
Family
ID=35494891
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2005128014A Active JP4126053B2 (ja) | 2004-05-06 | 2005-04-26 | 鹿角霊芝を含有した健康食品の製造方法 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP4126053B2 (ja) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007077606A1 (ja) * | 2005-12-28 | 2007-07-12 | Ahc Co., Ltd | 代替治療薬の効力増強剤およびこれを利用する抗癌性製剤 |
CN102670765A (zh) * | 2012-05-28 | 2012-09-19 | 北京师范大学 | 一种治疗癌痛的中药组合物 |
US20150147352A1 (en) * | 2012-07-05 | 2015-05-28 | Nutramax Laboratories, Inc. | Compositions comprising sulforaphane or a sulforaphane precursor and a mushroom extract or powder |
US20160184376A1 (en) * | 2014-08-20 | 2016-06-30 | Osato International Inc. | Method for Promoting ATP Production and Mitochondrial Activity, and Immunostimulating in Type 2 Diabetic Patients |
-
2005
- 2005-04-26 JP JP2005128014A patent/JP4126053B2/ja active Active
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007077606A1 (ja) * | 2005-12-28 | 2007-07-12 | Ahc Co., Ltd | 代替治療薬の効力増強剤およびこれを利用する抗癌性製剤 |
CN102670765A (zh) * | 2012-05-28 | 2012-09-19 | 北京师范大学 | 一种治疗癌痛的中药组合物 |
US20150147352A1 (en) * | 2012-07-05 | 2015-05-28 | Nutramax Laboratories, Inc. | Compositions comprising sulforaphane or a sulforaphane precursor and a mushroom extract or powder |
US10960057B2 (en) * | 2012-07-05 | 2021-03-30 | Nutramax Laboratories, Inc. | Compositions comprising sulforaphane or a sulforaphane precursor and a mushroom extract or powder |
US11654186B2 (en) | 2012-07-05 | 2023-05-23 | Nutramax Laboratories, Inc. | Compositions comprising sulforaphane or a sulforaphane precursor and a mushroom extract or powder |
US20160184376A1 (en) * | 2014-08-20 | 2016-06-30 | Osato International Inc. | Method for Promoting ATP Production and Mitochondrial Activity, and Immunostimulating in Type 2 Diabetic Patients |
Also Published As
Publication number | Publication date |
---|---|
JP4126053B2 (ja) | 2008-07-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4521447B2 (ja) | 酵素含有の健康食品の製造方法及び健康食品 | |
CN104824548B (zh) | 枸杞复合保健酵素及其制备方法 | |
KR101486648B1 (ko) | 꽃송이버섯 발효식품 및 그 제조방법 | |
Pendón et al. | Water kefir: Factors affecting grain growth and health‐promoting properties of the fermented beverage | |
KR101439321B1 (ko) | 배 가공 부산물을 이용한 기능성 배 발효액 및 이의 사용 방법 | |
JP4302684B2 (ja) | コタラヒンブツ葉エキスを含有した健康食品の製造方法 | |
KR100821713B1 (ko) | 차가버섯을 함유한 막걸리 및 그 제조방법 | |
KR101697107B1 (ko) | 조청을 이용한 유산균 발효 음료의 제조방법 및 이에 의해 제조된 유산균 발효 음료 | |
JP4126053B2 (ja) | 鹿角霊芝を含有した健康食品の製造方法 | |
JP3370302B2 (ja) | パパイヤを用いた健康食品の製造方法 | |
CN110089651A (zh) | 一种辣椒叶酵素饮料的生产方法 | |
KR20150105700A (ko) | 버섯을 이용한 식품첨가물의 제조방법 및 식품첨가물을 포함한 밀가루 반죽 | |
KR101177786B1 (ko) | 꿀벌 화분 발효액, 프로폴리스, 벌꿀 및 로얄 제리를 함유하는 건강식품의 제조 방법 | |
JP2007097500A (ja) | コタラヒンブツを含有した健康食品の製造方法 | |
JP2008266177A (ja) | 脳保護剤 | |
KR20160126591A (ko) | 인삼류 발효 추출물의 제조방법, 이의 방법으로 제조된 인삼류 발효 추출물 및 이를 포함하는 건강기능식품 | |
JP2012158536A (ja) | 抗うつ剤 | |
KR20160055292A (ko) | 효모 및 천연효소를 이용한 발효삼채 제조 및 갈증해소용 혼합음료 제조방법 | |
KR101089291B1 (ko) | 버섯 발효 식이 섬유의 제조 방법 | |
JP3762364B2 (ja) | ミミズと蟻を用いた健康食品の製造方法 | |
KR101713176B1 (ko) | 항산화 활성을 갖는 한방발효 조성물 및 이의 제조방법 | |
KR102423419B1 (ko) | 부종 관리에 도움을 주는 액상 차의 제조 방법 | |
JP4019193B2 (ja) | アガリクスタケを含有した健康食品の製造方法 | |
KR101925124B1 (ko) | 무가당 상태로 미생물 효소가 함유되어 제공되는 마늘 또는 레몬 발효음료 및 이의 제조방법 | |
JP2006265142A (ja) | 体脂肪の蓄積抑制または低減剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20060421 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20080110 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20080131 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20080327 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20080421 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20080509 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 Ref document number: 4126053 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110516 Year of fee payment: 3 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120516 Year of fee payment: 4 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130516 Year of fee payment: 5 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313117 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |